&Partners’s Vivani Medical VANI Stock Holding History

&Partners’s Portfolio VANI Stock Details VANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-2,165	Closed	-$43K	–	167
2019 Q3	$43K	Hold	2,165	–	–	0.06%	153
2019 Q2	$42K	Hold	2,165	–	–	0.06%	147
2019 Q1	$41K	Buy	+2,165	New	+$42.2K	0.06%	144

Other funds holding VANI

VVM

Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SPC

Sigma Planning Corp Ann Arbor, Michigan $3.97B AUM 32.34% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

HSA

HBK Sorce Advisory Erie, Pennsylvania $5.27B AUM 19.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fore Capital New York $338M AUM 10.07% 1-Year Est. Return

BRWM

B. Riley Wealth Management Memphis, Tennessee $962M AUM 8.45% 1-Year Est. Return

&Partners's VANI Position: Q4 2019 in Review

&Partners sold out of Vivani Medical (VANI) in Q4 2019, closing a stake of 2,165 shares — an estimated $43K sold.

&Partners first reported a position in VANI in Q1 2019 and held it in 3 quarters. The position peaked at $43K in Q3 2019. 30 funds tracked by Wall St. Rank hold VANI as of Q4 2019.

&Partners reported no remaining Vivani Medical position as of Q4 2019 after selling out during the quarter.
&Partners sold 2,165 Vivani Medical shares in Q4 2019, an estimated $43K.
&Partners first reported a position in Vivani Medical in Q1 2019 and held it in 3 quarters.
&Partners's Vivani Medical position peaked at $43K in Q3 2019.
30 funds tracked by Wall St. Rank held Vivani Medical as of Q4 2019.

Based on &Partners's 13F filing for Q4 2019, filed 10 Jan 2020.